![Starting dose selection and dose escalation for oncology small molecule first-in-patient trials: learnings from a survey of FDA-approved drugs | SpringerLink Starting dose selection and dose escalation for oncology small molecule first-in-patient trials: learnings from a survey of FDA-approved drugs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00280-020-04202-0/MediaObjects/280_2020_4202_Fig3_HTML.png)
Starting dose selection and dose escalation for oncology small molecule first-in-patient trials: learnings from a survey of FDA-approved drugs | SpringerLink
![A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714410000364-gr1.jpg)
A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect
![Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter](https://pbs.twimg.com/media/Dzbock-W0AAdfeK.jpg)
Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter
![Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter](https://pbs.twimg.com/media/DzbopH4WwAA61F9.jpg)
Bertrand Delsuc on Twitter: "Straathof/UCL - clinical trial using a rolling 6 design 14/14=100% manuf success rate product characteristics https://t.co/CamF3tdlCU" / Twitter
![A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714410000364-gr2.jpg)
A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials - ScienceDirect
![Agave Ironworks [RH001-6] Wrought Iron Rolling Track Barn Door Hardware Kit - Basic Smooth Design - 6' Track | Decorative Hardware, Cabinet, Door, Shutter, Window Hardware, Bath & Architectural Accessories Agave Ironworks [RH001-6] Wrought Iron Rolling Track Barn Door Hardware Kit - Basic Smooth Design - 6' Track | Decorative Hardware, Cabinet, Door, Shutter, Window Hardware, Bath & Architectural Accessories](https://www.martellhardware.com/Hardware/Agave-Ironworks/Large/Barn-Door-Hardware/RH001-Wrought-Iron-Barn-Door-Hardware-Kit-001.jpg)